Tecsys (TCS) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
15 May, 2026Opening remarks and agenda
Meeting opened with introductions of board members and explanation of virtual meeting procedures.
Agenda included procedural matters, financial review, election of directors, auditor appointment, and Q&A.
Financial performance review
Revenue grew by 3% in 2025, with SaaS revenue up 29% and hardware revenue down 39%.
Adjusted EBITDA increased 39% to $13.4 million, driven by SaaS margin expansion.
SaaS margin rose from 50% in 2023 to 61% in 2025, with a target of 65% in 2026.
Cash and short-term investments exceeded $39 million at year-end, with no debt.
Board and executive committee updates
Eight directors were nominated and elected to serve until the next annual meeting.
KPMG LLP was reappointed as auditors, with directors authorized to fix remuneration.
Latest events from Tecsys
- Record SaaS-driven revenue, margin expansion, and raised FY25 revenue outlook.TCS
Q3 20258 Jul 2026 - SaaS revenue up 25%, total revenue $46M, and adjusted EBITDA up 24% with strong healthcare growth.TCS
Q1 20262 Jul 2026 - Record SaaS-driven revenue, margin expansion, and strong FY27 growth outlook.TCS
Q4 202630 Jun 2026 - SaaS-driven growth and innovation position the company to capture a $3B ARR supply chain market.TCS
Investor presentation30 Jun 2026 - Directors and auditors re-elected, SaaS revenue surged, and strategic healthcare focus reaffirmed.TCS
AGM 202415 May 2026 - SaaS revenue rose 33%, bookings 57%, and guidance was reaffirmed amid strong governance actions.TCS
Q1 202522 Apr 2026 - SaaS revenue up 29% year-over-year, fueling record profit and strong healthcare momentum.TCS
Q4 202522 Apr 2026 - Record SaaS growth, TecsysIQ launch, and cost-saving measures drive strong Q3 results.TCS
Q3 20265 Mar 2026 - Record SaaS growth and margin gains drive strong FY2024 results and positive outlook.TCS
Q4 20243 Feb 2026